Statistics

Total Visits

Views
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer 29

Total Visits Per Month

January 2024 February 2024 March 2024 April 2024 May 2024 June 2024 July 2024
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer 1 1 4 1 0 1 0

File Visits

Views
Palafox_nc_high.pdf 23

Top country views

Views
United States 25
Spain 2
Greece 1
Malaysia 1

Top cities views

Views
San Ramon 5
Boardman 3
Fairfield 3
Mountain View 3
Ashburn 2
Barcelona 2
Cambridge 2
Redmond 2
San Diego 2
Ann Arbor 1

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking